RT Journal Article SR Electronic T1 Social skills group training (KONTAKTTM) for Chinese autistic children: a feasibility wait-list RCT protocol JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2023.10.30.23296686 DO 10.1101/2023.10.30.23296686 A1 Lao, Uchong A1 Zhu, Huilin A1 Liang, Fengjing A1 Bai, Wuxia A1 Yin, Peipei A1 Huang, Xiaoqian A1 Girdler, Sonya A1 Bölte, Sven A1 Zou, Xiaobing YR 2023 UL http://medrxiv.org/content/early/2023/10/30/2023.10.30.23296686.abstract AB Introduction Challenges in social communication and interaction are common among school-aged autistic children in mainstream society settings. Although social skills group training (SSGT) is effective in promoting positive psycho-social functioning outcomes in autistic children, there is no standardised evidence-based SSGT in Mainland China to date. Therefore, the main aim of this study is to evaluate the feasibility and acceptability of the culturally-adapted 16-session version of the KONTAKTTM programme in Chinese autistic children. In addition, this study will provide preliminary effectiveness and cost-effectiveness data on the 16-session Chinese version of KONTAKTTM.Methods and analysis This is a randomised, single-blinded, wait-list controlled feasibility study with 36 autistic children aged 8–12 years with Intelligence Quotient over 70. They will be assigned to either the immediate training group (ITG) or the delayed training group (DTG) based on gender. Feasibility will be measured by the mixed-methods data of acceptability and adherence of participants, parents, and providers. Preliminary effectiveness and cost-effectiveness will be assessed by quantitative data collected at five-time points. The main outcome is the improvement in social skills as measured by the Contextual Assessment of Social Skills (CASS). Other outcomes include autism traits, adaptive functioning, self-assertiveness, psycho-social functioning, parental reflective functioning, and school support. Common process factors and their effects on outcomes will also be explored. Cost-effectiveness will consider both societal and healthcare perspectives.Ethics and dissemination The current study protocol has been reviewed and ethics approval obtained from the Ethical Board Committee at the Third Affiliated Hospital of Sun Yat-sen University (II2023-119-01). The trial has pre-registered in Chinese Clinical Trials (ChiCTR2300072136) on 05 June 2023. The results of this trial will be actively disseminated through manuscript publications and conference presentations.Strengths and limitations of this studyComprehensive assessment via diverse outcome acquisition methods and multiple informants.Systematic cultural adaptation using the Integrative Cultural Adaptation Framework (ICAF) ensures the appropriateness of the Chinese version of KONTAKTTM.Collect data on readiness for change, providing insights into “help-seeker” effects.Limited generalisability due to a single study site, location-specific inclusion, and absence of active comparator.Uncertain psychometric properties of certain measures due to a lack of Chinese population data.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialChiCTR2300072136Clinical Protocols https://www.chictr.org.cn/showproj.html?proj=195469 Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Ethical Board Committee of the Third Affiliated Hospital of Sun Yat-sen University gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe ethical consent and funding documents have been reviewed by the review board of the Chinese Clinical Trial Registry and are available for review by the Editorial Office. Anonymised data related to this study will be available from the corresponding author upon reasonable request after study completion and publication of the study. The final dataset generated during this study will upload to the Research Data Deposit of Sun Yat-sen University. Trial results will be reported and published in scientific journals.